Clinical Chemistry, Malmö
1 – 10 of 1368
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
A 25-year evaluation of direct local international normalized ratio calibration of the Owren type prothrombin time method in Sweden
- Contribution to journal › Article
-
Mark
Plasma pTau 217/β-amyloid 1–42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology
- Contribution to journal › Article
-
Mark
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease : 5-year Results from the IMPACT Study
- Contribution to journal › Article
-
Mark
Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model
- Contribution to journal › Article
-
Mark
Targeting P2RY2 reprograms tumor immunity and inhibits tumor growth in non-small cell lung cancer
- Contribution to journal › Article
-
Mark
Molecular signatures of oocyte viability identified by follicular fluid proteomics
- Contribution to journal › Article
-
Mark
Childhood cancer survivors with premature ovarian insufficiency have low bone mineral density at long term follow-up
(2026) In Bone
- Contribution to journal › Article
-
Mark
Transcriptome-wide association studies implicate RCC1 and PHACTR4 in prostate cancer survival
- Contribution to journal › Article
-
Mark
Shiga toxin delivery in extracellular vesicles induces high mortality and severe kidney injury in a Gb3-dependent manner
- Contribution to journal › Article
-
Mark
Using 18F-FDG PET/CT-derived body composition features to predict lymphovascular invasion in non-small cell lung cancer
- Contribution to journal › Article
